InsiderClue
Insiders · Profile

Brannelly Paul

Executive Vice President & CFO at COLLEGIUM PHARMACEUTICAL · SVP, FINANCE & ADMIN, TREAS at Karyopharm Therapeutics. Filing since 13 May 2014. CIK 0001394936

COLL COLLEGIUM PHARMACEUTICAL, INC Executive Vice President & CFO · 2 trades KPTI Karyopharm Therapeutics Inc. SVP, FINANCE & ADMIN, TREAS · 3 trades
Company
Date
Role
Action
Shares
Amount
Of holding
COLL COLLEGIUM PHARMACEUTICAL, INC
21 Jun 2018
Executive Vice President & CFO
Sold, plan not stated
10,000
$279.17K
7.5%
COLL COLLEGIUM PHARMACEUTICAL, INC
12 May 2017
Executive Vice President & CFO
Bought
10,000
$91.80K
10.0%
KPTI Karyopharm Therapeutics Inc.
15 May 2014
SVP, FINANCE & ADMIN, TREAS
Bought
700
$18.17K
1.1%
KPTI Karyopharm Therapeutics Inc.
14 May 2014
SVP, FINANCE & ADMIN, TREAS
Bought
800
$21.54K
1.2%
KPTI Karyopharm Therapeutics Inc.
13 May 2014
SVP, FINANCE & ADMIN, TREAS
Bought
1,000
$28.06K
1.6%
5 decisions on file.